Mirae Asset Global ETFs Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	49,227 +182	+0.4%	+$3.96K	﹤0.01%	1458
2025 Q4	$1.03M	Buy	49,045 +2,204	+5%	+$38.5K	﹤0.01%	1502
2025 Q3	$722K	Sell	46,841 -6,004	-11%	-$78.6K	﹤0.01%	1679
2025 Q2	$493K	Sell	52,845 -3,997	-7%	-$44K	﹤0.01%	1826
2025 Q1	$705K	Buy	56,842 +3,094	+6%	+$43.6K	﹤0.01%	1672
2024 Q4	$706K	Buy	53,748 +1,811	+3%	+$31K	﹤0.01%	1737
2024 Q3	$997K	Buy	51,937 +4,564	+10%	+$94.3K	﹤0.01%	1542
2024 Q2	$971K	Buy	+47,373	New	+$991K	﹤0.01%	1470

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SNDX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Syndax Pharmaceuticals (SNDX) stake by 0.37% in Q1 2026, buying an estimated $3.96K and bringing the position to 49,227 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Mirae Asset Global ETFs Holdings first reported a position in SNDX in Q2 2024 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Mirae Asset Global ETFs Holdings held 49,227 shares of Syndax Pharmaceuticals worth $1.14M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 182 Syndax Pharmaceuticals shares in Q1 2026, an estimated $3.96K.
Syndax Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1458 holding.
Mirae Asset Global ETFs Holdings first reported a position in Syndax Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.